7-(4-Methoxybenzylamino)-4-nitrobenzoxadiazole
7-(4-Methoxybenzylamino)-4-nitrobenzoxadiazole structure
|
Common Name | 7-(4-Methoxybenzylamino)-4-nitrobenzoxadiazole | ||
|---|---|---|---|---|
| CAS Number | 33984-50-8 | Molecular Weight | 300.26900 | |
| Density | 1.438 g/cm3 | Boiling Point | 500.8ºC at 760 mmHg | |
| Molecular Formula | C14H12N4O4 | Melting Point | 178-182ºC | |
| MSDS | Chinese USA | Flash Point | 256.7ºC | |
Use of 7-(4-Methoxybenzylamino)-4-nitrobenzoxadiazoleMBD (7-(p-Methoxybenzylamino)-4-nitrobenz-2,1,3-oxadiazole), a new fluorescent probe for protein and nucleoprotein conformation, is applied to bacterial ribosomes and to bovine trypsinogen and trypsin. MBD is strongly fluorescent upon binding to a hydrophobic area of a macromolecule[1][2]. |
| Name | N-[(4-methoxyphenyl)methyl]-4-nitro-2,1,3-benzoxadiazol-7-amine |
|---|---|
| Synonym | More Synonyms |
| Description | MBD (7-(p-Methoxybenzylamino)-4-nitrobenz-2,1,3-oxadiazole), a new fluorescent probe for protein and nucleoprotein conformation, is applied to bacterial ribosomes and to bovine trypsinogen and trypsin. MBD is strongly fluorescent upon binding to a hydrophobic area of a macromolecule[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.438 g/cm3 |
|---|---|
| Boiling Point | 500.8ºC at 760 mmHg |
| Melting Point | 178-182ºC |
| Molecular Formula | C14H12N4O4 |
| Molecular Weight | 300.26900 |
| Flash Point | 256.7ºC |
| Exact Mass | 300.08600 |
| PSA | 106.00000 |
| LogP | 3.34790 |
| Index of Refraction | 1.691 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Safety Phrases | 22-24/25 |
| RIDADR | NONH for all modes of transport |
| HS Code | 2934999090 |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
Coordinated epigenetic remodelling of transcriptional networks occurs during early breast carcinogenesis.
Clin. Epigenetics. 7 , 52, (2015) Dysregulation of the epigenome is a common event in malignancy; however, deciphering the earliest cancer-associated epigenetic events remains a challenge. Cancer epigenome studies to date have primari... |
|
|
Impact of the F508del mutation on ovine CFTR, a Cl- channel with enhanced conductance and ATP-dependent gating.
J. Physiol. 593 , 2427-46, (2015) Malfunction of the cystic fibrosis transmembrane conductance regulator (CFTR), a gated pathway for chloride movement, causes the common life-shortening genetic disease cystic fibrosis (CF). Towards th... |
|
|
Nutritional evaluation of Australian microalgae as potential human health supplements.
PLoS ONE 10(2) , e0118985, (2015) This study investigated the biochemical suitability of Australian native microalgal species Scenedesmus sp., Nannochloropsis sp., Dunaliella sp., and a chlorophytic polyculture as nutritional suppleme... |
| Benzofurazan,4-((p-methoxybenzyl)amino)-7-nitro |
| 4-(4-Methoxybenzylamino)-7-nitrobenzofurazan |
| t56 bnonj fnw im1r do1[wln] |
| s-benzofurazanamine,N-[(4-methoxyphenyl)methyl]-7-nitro |
| 4-(4-Methoxybenzylamino)-7-nitro-2,1,3-benzoxadiazole |
| 7-(p-Methoxybenzylamino)-4-nitrobenz-2-oxa-1,3-diazol |
| 4-(4-methoxybenzylamino)-7-nitrobenzofurazane |
| MFCD00042778 |
| 4-(4-Methoxybenzylamino)-7-nitro-2,1,3-benzoxadiazole,MBD |
| EINECS 251-775-9 |
| MBD |